Copyright
©The Author(s) 2005.
World J Gastroenterol. Jul 28, 2005; 11(28): 4300-4304
Published online Jul 28, 2005. doi: 10.3748/wjg.v11.i28.4300
Published online Jul 28, 2005. doi: 10.3748/wjg.v11.i28.4300
Table 2 Different chemotherapeutic effect of gastrointestinal cancers
| Therapeutic effect | Gastric cancer | Colorectal cancer | Total | |||
| X group | C group | X group | C group | X group | C group | |
| n | 24 | 25 | 31 | 34 | 55 | 59 |
| CR (n) | 1 | 1 | 1 | 0 | 2 | 1 |
| PR (n) | 13 | 10 | 14 | 14 | 27 | 24 |
| NC (n) | 5 | 10 | 12 | 14 | 17 | 24 |
| PD (n) | 5 | 4 | 4 | 6 | 9 | 10 |
| CR+PR (n) | 14 | 11 | 17 | 14 | 29 | 25 |
| (%) | 58.3 | 44.0 | 54.8 | 41.2 | 52.7 | 42.4 |
| TTP (mo) | 7.0±1.3a | 5.4±0.9 | 7.8±1.9a | 6.7±2.0 | 7.4±1.7a | 6.0±1.5 |
| 1-yr survival (%) | 41.7a | 36.0 | 64.5a | 52.9 | 53.1a | 44.5 |
- Citation: Fan L, Liu WC, Zhang YJ, Ren J, Pan BR, Liu DH, Chen Y, Yu ZC. Oral Xeloda plus bi-platinu two-way combined chemotherapy in treatment of advanced gastrointestinal malignancies. World J Gastroenterol 2005; 11(28): 4300-4304
- URL: https://www.wjgnet.com/1007-9327/full/v11/i28/4300.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i28.4300